proadifen has been researched along with Lymph Node Metastasis in 1 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kretschy, N | 1 |
| Teichmann, M | 1 |
| Kopf, S | 1 |
| Atanasov, AG | 1 |
| Saiko, P | 1 |
| Vonach, C | 1 |
| Viola, K | 1 |
| Giessrigl, B | 1 |
| Huttary, N | 1 |
| Raab, I | 1 |
| Krieger, S | 1 |
| Jäger, W | 1 |
| Szekeres, T | 1 |
| Nijman, SM | 1 |
| Mikulits, W | 1 |
| Dirsch, VM | 1 |
| Dolznig, H | 1 |
| Grusch, M | 1 |
| Krupitza, G | 1 |
1 other study available for proadifen and Lymph Node Metastasis
| Article | Year |
|---|---|
In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Acetohexamide; Antineoplastic Combined Chemotherapy Prot | 2013 |